BridgeBio Pharma Inc.

10/07/2022 | Press release | Distributed by Public on 10/07/2022 05:33

BridgeBio Pharma to Present New Data on its Novel Approaches to RAS-driven Cancers at the Fourth RAS Initiative Symposium